DermTech
Earnings Roundup: DermTech, Exagen, Lucid Diagnostics, Oncocyte
These genomics and molecular diagnostics firms posted their quarterly financial results this week.
DermTech to Lay off 100 Employees in Restructuring, Explore Strategic Alternatives
The news follows a delisting warning from the Nasdaq the company received earlier this week for not meeting the minimum bid price requirement.
DermTech Receives Delisting Warning From Nasdaq
The company has until mid-October to regain compliance with the stock market's $1 per share minimum bid price requirement.
In Brief This Week: IVDR, Personalis, DermTech, BGI Genomics, Bionano Genomics, More
News items for the week of Feb. 26, 2024.
DermTech Further Restructures, Trims Workforce by Additional 30 Employees
Combined with a restructuring announced last June, the company anticipates some $40 million in total operating expense reductions.